SR27897
|
|
SR27897 속성
- 밀도
- 1.49±0.1 g/cm3(Predicted)
- 저장 조건
- Desiccate at +4°C
- 용해도
- DMSO: 60°C로 가열 시 ≥10mg/mL
- 산도 계수 (pKa)
- 4.00±0.10(Predicted)
- 물리적 상태
- 가루
- 색상
- 흰색에서 황갈색까지
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Danger | |||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||
예방조치문구: |
|
SR27897 C화학적 특성, 용도, 생산
용도
SR 27897 is a human cholecystokinin type 1 (CCK1) competitive antagonist.생물학적 활성
Potent, non-peptide CCK 1 receptor antagonist that displays > 33-fold selectivity over CCK 2 receptors (EC 50 values are 6 and 200 nM respectively). Causes an increase in plasma leptin levels and increases food intake in rats in vivo .SR27897 준비 용품 및 원자재
원자재
준비 용품
SR27897 공급 업체
글로벌( 38)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32480 | 60 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 19892 | 58 |
Aladdin Scientific | +1-833-552-7181 |
sales@aladdinsci.com | United States | 57511 | 58 |
3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 |
3bsc@sina.com | China | 15848 | 69 |
EMMX Biotechnology LLC | 888-539-0666 |
info@emmx.com | United States | 8449 | 60 |
Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 |
info@efebio.com | China | 9709 | 58 |
Tianjin Kailiqi Biotechnology Co., Ltd. | 15076683720 |
klq@cw-bio.com | China | 3444 | 55 |
MQ (shanghai) Pharmaceuticals Co., Ltd. | 13761635123 |
1014988033@qq.com | China | 4979 | 55 |
ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 |
sales@chemegen.com | China | 11289 | 58 |
ShangHai ChuanQian Chemcial Technique Centre | 15869524721 |
3525679403@qq.com | China | 3915 | 58 |
SR27897 관련 검색:
NA
SR-717
SRT3025
SR9009
SR8278
SR19881
SR-9243
SRPK inhibitor
SR 1078
N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide
SRI 31215
SR 0987
SR17018
N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine
4-Quinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-
2-Chloro-N-(6-methoxy-4-quinolinyl)-5-nitrobenzamide
SR-4835
SR18662